Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,778 across all filing types
Latest filing 2016-08-31 Declaration of Voting R…
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
Evotec AG: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Total Voting Rights Announcement' and explicitly references Article 26a of the WpHG (German Securities Trading Act). It announces the 'Publication of total number of voting rights' and details a 'Conditional capital increase' effective on 31.08.2016, resulting in a new total of 132,842,466 voting rights. This type of announcement, concerning the total number of shares/voting rights, is a specific regulatory disclosure. While it is a regulatory announcement, it is not a general 'RNS' fallback. It specifically relates to capital structure changes (conditional capital increase) and the resulting voting rights count. Among the provided codes, 'SHA' (Share Issue/Capital Change) is the most appropriate fit for an announcement detailing a capital increase and the resulting total voting rights, as it directly impacts the share capital structure. It is not a general earnings release (ER), a full report (10-K/IR), or a director's dealing (DIRS).
2016-08-31 English
Declaration of Voting Results & Voting Rights Announcements 2016
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a press release announcing a $3.5 billion private placement of common equity. This action involves raising capital through the issuance of equity, which directly relates to the company's capital structure and financing activities. The key phrases are "Announces $3.5 Billion Private Placement," "Substantial Equity Raise," and "The net proceeds from the private placement will be used to strengthen the company’s balance sheet through repaying portions of its debt." This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). Although it mentions the 10-K in the forward-looking statements section, the primary subject is the financing event itself, not the annual report.
2016-08-23 English
DGAP-DD: Evotec AG english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains detailed information regarding a transaction by a 'person discharging managerial responsibilities' (Dr. Werner Lanthaler, Member of the managing body) involving the acquisition of shares. This directly matches the definition for Director's Dealing reports.
2016-08-18 English
EVOTEC AG REPORTS RESULTS OF FIRST HALF OF 2016
Earnings Release Classification · 100% confidence The document explicitly states in the title and body that it reports the 'RESULTS OF FIRST HALF OF 2016' and provides detailed financial figures for H1 2016 (January to June 2016), including revenues, EBITDA, and segment performance. This content aligns perfectly with the definition of a comprehensive financial report for a period shorter than a year. The presence of detailed financial tables and performance commentary confirms it is the report itself, not just an announcement of the report. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2016
2016-08-10 English
Präsentation H1
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Evotec AG, H1 2016 Interim Report' and contains detailed financial performance metrics, operational highlights, revenue breakdowns, and strategic outlooks for the first half of the fiscal year. It is a comprehensive report containing actual financial data and analysis, not merely an announcement or a certification. Therefore, it is classified as an Interim/Quarterly Report. H1 2016
2016-08-10 English
EVOTEC ACHIEVES CLINICAL DEVELOPMENT MILESTONE AS PART OF ITS MULTI-TARGET ALLIANCE WITH BAYER IN ENDOMETRIOSIS
Regulatory Filings Classification · 95% confidence The document is titled 'News Details' and begins with a date and a headline announcing a clinical development milestone and a corresponding payment from Bayer to Evotec. It uses keywords like 'DGAP-News', 'Corporate', and 'News Details'. This format strongly suggests a press release or a general corporate announcement disseminated via a news service (DGAP). Since it is not a full financial report (10-K, IR), an earnings release (ER), or a specific regulatory filing like a Director's Dealing (DIRS) or Capital Change (SHA), the most appropriate classification is the general regulatory announcement/news category, which is RNS (Regulatory Filings) as per the provided definitions, or potentially an Earnings Release (ER) if it contained financial results, but here it is a specific operational/partnership milestone payment. Given the nature of announcing a partnership milestone payment, RNS serves as the best fit for a general corporate news item that isn't a core financial report or a specific event like a dividend or management change. It is not short enough to be a simple RPA.
2016-08-04 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.